bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)

C158H147F3N40Pt5 — CID 157402124

About bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)

bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) (PubChem CID 157402124) has the molecular formula C158H147F3N40Pt5 and a molecular weight of 3638.58 g/mol. Its IUPAC name is bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene).

Molecular Properties

• Compound Name: bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)
• PubChem CID: 157402124
• Molecular Formula: C158H147F3N40Pt5
• Molecular Weight: 3638.58 g/mol
• Exact Mass: 3636.09
• IUPAC Name: bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)
• SMILES: CC1(C)CCCc2c1n[n-]c2-c1ncnc2ccccc12.CC1(C)CCCc2c1n[n-]c2-c1ncnc2ccccc12.CC12CCC(c3c1n[n-]c3-c1ncnc3ccccc13)C2(C)C.CC12CCC(c3c1n[n-]c3-c1ncnc3ccccc13)C2(C)C.Cc1c(C(C)(C)C)n[n-]c1-c1ncnc2ccccc12.Cc1c(C(C)(C)C)n[n-]c1-c1ncnc2ccccc12.Cc1cc(-c2ncnc3ccccc23)[n-]n1.FC(F)(F)c1cc(-c2ncnc3ccccc23)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1ccc2c(-c3[n-]nc4c3CCCC4)ncnc2c1.c1ccc2c(-c3[n-]nc4c3CCCC4)ncnc2c1
• InChI: InChI=1S/2C19H19N4.2C17H17N4.2C16H17N4.2C15H13N4.C12H6F3N4.C12H9N4.5Pt/c2*1-18(2)12-8-9-19(18,3)17-14(12)16(22-23-17)15-11-6-4-5-7-13(11)20-10-21-15;2*1-17(2)9-5-7-12-15(20-21-16(12)17)14-11-6-3-4-8-13(11)18-10-19-14;2*1-10-13(19-20-15(10)16(2,3)4)14-11-7-5-6-8-12(11)17-9-18-14;2*1-3-7-12-10(5-1)14(17-9-16-12)15-11-6-2-4-8-13(11)18-19-15;13-12(14,15)10-5-9(18-19-10)11-7-3-1-2-4-8(7)16-6-17-11;1-8-6-11(16-15-8)12-9-4-2-3-5-10(9)13-7-14-12;;;;;/h2*4-7,10,12H,8-9H2,1-3H3;2*3-4,6,8,10H,5,7,9H2,1-2H3;2*5-9H,1-4H3;2*1,3,5,7,9H,2,4,6,8H2;1-6H;2-7H,1H3;;;;;/q10*-1;5*+2
• InChIKey: BNHISZJBGUMWTE-UHFFFAOYSA-N
• XLogP: 30.35
• TPSA: 527.70 Ų
• H-Bond Acceptors: 30
• Rotatable Bonds: 10
• Heavy Atoms: 206
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3638.58
LogP ≤ 5	30.35
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	30

Frequently Asked Questions

What is the IUPAC name of bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)?

The IUPAC name of bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) (CID 157402124) is bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene).

What is the SMILES notation for bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)?

The canonical SMILES for bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) is CC1(C)CCCc2c1n[n-]c2-c1ncnc2ccccc12.CC1(C)CCCc2c1n[n-]c2-c1ncnc2ccccc12.CC12CCC(c3c1n[n-]c3-c1ncnc3ccccc13)C2(C)C.CC12CCC(c3c1n[n-]c3-c1ncnc3ccccc13)C2(C)C.Cc1c(C(C)(C)C)n[n-]c1-c1ncnc2ccccc12.Cc1c(C(C)(C)C)n[n-]c1-c1ncnc2ccccc12.Cc1cc(-c2ncnc3ccccc23)[n-]n1.FC(F)(F)c1cc(-c2ncnc3ccccc23)[n-]n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1ccc2c(-c3[n-]nc4c3CCCC4)ncnc2c1.c1ccc2c(-c3[n-]nc4c3CCCC4)ncnc2c1.

What is the InChIKey of bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)?

The InChIKey is BNHISZJBGUMWTE-UHFFFAOYSA-N. The full InChI is InChI=1S/2C19H19N4.2C17H17N4.2C16H17N4.2C15H13N4.C12H6F3N4.C12H9N4.5Pt/c2*1-18(2)12-8-9-19(18,3)17-14(12)16(22-23-17)15-11-6-4-5-7-13(11)20-10-21-15;2*1-17(2)9-5-7-12-15(20-21-16(12)17)14-11-6-3-4-8-13(11)18-10-19-14;2*1-10-13(19-20-15(10)16(2,3)4)14-11-7-5-6-8-12(11)17-9-18-14;2*1-3-7-12-10(5-1)14(17-9-16-12)15-11-6-2-4-8-13(11)18-19-15;13-12(14,15)10-5-9(18-19-10)11-7-3-1-2-4-8(7)16-6-17-11;1-8-6-11(16-15-8)12-9-4-2-3-5-10(9)13-7-14-12;;;;;/h2*4-7,10,12H,8-9H2,1-3H3;2*3-4,6,8,10H,5,7,9H2,1-2H3;2*5-9H,1-4H3;2*1,3,5,7,9H,2,4,6,8H2;1-6H;2-7H,1H3;;;;;/q10*-1;5*+2.

What are the key properties of bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene)?

bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) has a molecular weight of 3638.58 g/mol, XLogP of 30.35, 10 rotatable bonds, 0 hydrogen bond donors, and 30 hydrogen bond acceptors.

Where does this data come from?

All data for bis(4-(3-tert-butyl-4-methylpyrazol-1-id-5-yl)quinazoline);bis(4-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)quinazoline);4-(5-methylpyrazol-2-id-3-yl)quinazoline;pentakis(platinum(2+));bis(4-(4,5,6,7-tetrahydroindazol-2-id-3-yl)quinazoline);4-[3-(trifluoromethyl)pyrazol-1-id-5-yl]quinazoline;bis(1,10,10-trimethyl-5-quinazolin-4-yl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene) is sourced from PubChem (CID 157402124), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).